GenHealth

GenHealth in Surprise, Arizona offers Spravato (esketamine) therapy for adults with major depressive disorder who have not found adequate relief from previous antidepressant treatments. Spravato is a nasal spray containing esketamine, a derivative of ketamine, used in conjunction with an oral antidepressant.

The spray is self-administered under the supervision of a GenHealth provider, with patients remaining at the facility for at least two hours of monitoring after each dose. Esketamine works on the glutamate system in the brain, helping restore synaptic connections damaged by depression and often easing symptoms more rapidly than standard oral medications.

The treatment process typically starts with twice-weekly dosing for the first four weeks, followed by a maintenance phase tailored to the patient's response. The Surprise location also provides TMS, psychiatric and mental health evaluation, medication management, and psychology services.